1Murphy MF, Waters AH. Immunological aspactsw of platlet transfusions Brtish Journal of Haemotology, 1995;60:409
2Eernisse JC, etal. Prevention of plate let repratoriness due to HLA, antibodies by administration of leakoyte- poor blood components. Exp Hematol, 1991;9:77
3O'connell B, et al. the value of 10 minute post ytrans fusion platelet counts. Trmas fuzion, 1998;28:66
4Parker RD, et al. Interaction effects analysis of platelet ransfusion dat. Transfusion, 1994;14:567
5Bis ship JF, et al. Clinical factors influencing the efficacy of pooled platelet transfusion. Blood, 1998;71:567
6Mofarland JG, Anderson AJ. Factons influncing the trarzfusion responce to HLA- selected aphersis donor platetet in patiemls.Br J Haematol, 1999;73:380
7Hill- zobet RL, et al, Orgen distribution and fute of human platclets studies of asplenic and splenongalic patients. Am J Hematol, 1996;23:231
8Sliohter SJ. Platlet tranzfusion the ropy Hematol Oncol Clin North AM, 1990;4:291
9Pamphlion DH, et al. De velopment of lymphocytoxnin and latlet reatove amtbodies. Vox sane, 1999;57:177
10Blamchette VS, et al. Allomimmunizaton to the PLAI platelt antigen. Br J Haematol, 1990;74:209
